UPCC 29822 The DOD Omics Consortium to Study the Origins of Ovarian Cancer (DOCSOOC)

Enrolling By Invitation
99 years or below
All
Phase N/A
50 participants needed
1 Location

Brief description of study

The objective of this consortium is to generate and utilize omics level data to elucidate the early steps in ovarian cancer (OvCa) initiation and provide the broader OvCa research community with a centralized resource of comprehensive omics datasets surveying the molecular landscapes of OvCa precursor lesions and their associated microenvironment. This work will provide immediate and long-term benefits toward the development of strategies to diagnose high-grade serous OvCa (HGSC), a deadly disease with no effective screening or early detection strategies. The proposed work will also directly build upon some of our seminal studies identifying serous tubal intraepithelial carcinoma (STIC) lesions of the fallopian tube (FT) as the origin of the majority of HGSCs.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 22-0931
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator